Tag: Vyzulta

In a head-to-head clinical study, Vyzulta demonstrated significantly greater intraocular pressure (IOP) reduction than Latanoprost. This distinction, however, is just one factor to consider when determining which is better, latanoprost or vyzulta, for managing glaucoma or ocular hypertension. The choice between these two prostaglandin eye drops depends on a patient's clinical needs, side effect profile, and cost considerations.

In clinical trials, the most commonly reported side effect for Latanoprostene Bunod ophthalmic solution, also known as Vyzulta, was eye redness, affecting approximately 6% of patients. This medication is used to lower intraocular pressure in patients with glaucoma or ocular hypertension. Beyond redness, patients may experience various other ocular and systemic side effects, some temporary and others potentially permanent.

In 2022, an estimated 4.2 million Americans were living with glaucoma [1.5.1]. For many, treatment begins with latanoprost, but the search for what is better than latanoprost arises due to side effects or insufficient pressure control, leading to a variety of effective alternatives.